% alzhub.org library filter % Source: https://alzhub.org/research?author=Scheltens+P&institution=I4210151833 % 15 entries, in the order the page lists them. Built from alzhub.org's own records. % 0 entries have no readable author in the source record and carry no author field. @article{prins2021-34044875, author = {Prins, N. D. and Harrison, J. E. and Chu, H. M. and Blackburn, K. and Alam, J. J. and Scheltens, P. and {REVERSE-SD Study Investigators}}, title = {{A phase 2 double-blind placebo-controlled 24-week treatment clinical study of the p38 alpha kinase inhibitor neflamapimod in mild Alzheimer's disease}}, journal = {Alzheimer's research \& therapy}, year = {2021}, doi = {10.1186/s13195-021-00843-2}, pmid = {34044875}, url = {https://doi.org/10.1186/s13195-021-00843-2} } @article{altomare2023-37155177, author = {Altomare, D. and Barkhof, F. and Caprioglio, C. and Collij, L. E. and Scheltens, P. and Lopes Alves, I. and Bouwman, F. and Berkhof, J. and others}, title = {{Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients: The AMYPAD-DPMS Randomized Clinical Trial}}, journal = {JAMA neurology}, year = {2023}, doi = {10.1001/jamaneurol.2023.0997}, pmid = {37155177}, url = {https://doi.org/10.1001/jamaneurol.2023.0997} } @article{vanloenhoud2019-31266904, author = {van Loenhoud, A. C. and van der Flier, W. M. and Wink, A. M. and Dicks, E. and Groot, C. and Twisk, J. and Barkhof, F. and Scheltens, P. and others}, title = {{Cognitive reserve and clinical progression in Alzheimer disease: A paradoxical relationship}}, journal = {Neurology}, year = {2019}, doi = {10.1212/wnl.0000000000007821}, pmid = {31266904}, url = {https://doi.org/10.1212/wnl.0000000000007821} } @article{verberk2021-36098162, author = {Verberk, I. M. W. and Laarhuis, M. B. and van den Bosch, K. A. and Ebenau, J. L. and van Leeuwenstijn, M. and Prins, N. D. and Scheltens, P. and Teunissen, C. E. and others}, title = {{Serum markers glial fibrillary acidic protein and neurofilament light for prognosis and monitoring in cognitively normal older people: a prospective memory clinic-based cohort study}}, journal = {The lancet. Healthy longevity}, year = {2021}, doi = {10.1016/s2666-7568(20)30061-1}, pmid = {36098162}, url = {https://doi.org/10.1016/s2666-7568(20)30061-1} } @article{scheltens2021-33667416, author = {Scheltens, P. and De Strooper, B. and Kivipelto, M. and Holstege, H. and Chételat, G. and Teunissen, C. E. and Cummings, J. and van der Flier, W. M.}, title = {{Alzheimer's disease}}, journal = {Lancet (London, England)}, year = {2021}, doi = {10.1016/s0140-6736(20)32205-4}, pmid = {33667416}, url = {https://doi.org/10.1016/s0140-6736(20)32205-4} } @article{honig2024-38377442, author = {Hönig, M. and Altomare, D. and Caprioglio, C. and Collij, L. and Barkhof, F. and Van Berckel, B. and Scheltens, P. and Farrar, G. and others}, title = {{Association Between Years of Education and Amyloid Burden in Patients With Subjective Cognitive Decline, MCI, and Alzheimer Disease}}, journal = {Neurology}, year = {2024}, doi = {10.1212/wnl.0000000000208053}, pmid = {38377442}, url = {https://doi.org/10.1212/wnl.0000000000208053} } @article{davidson2026-41109840, author = {Davidson, M. H. and Szarek, M. and Scheltens, P. and Vijverberg, E. and Hsieh, A. and Ditmarsch, M. and Kling, D. and Curcio, D. and others}, title = {{Effect of obicetrapib, a potent cholesteryl ester transfer protein inhibitor, on p-tau217 levels in patients with cardiovascular disease}}, journal = {The journal of prevention of Alzheimer's disease}, year = {2026}, doi = {10.1016/j.tjpad.2025.100394}, pmid = {41109840}, url = {https://doi.org/10.1016/j.tjpad.2025.100394} } @article{verhaar2021-35173707, author = {Verhaar, B. J. H. and Hendriksen, H. M. A. and de Leeuw, F. A. and Doorduijn, A. S. and van Leeuwenstijn, M. and Teunissen, C. E. and Barkhof, F. and Scheltens, P. and others}, title = {{Gut Microbiota Composition Is Related to AD Pathology}}, journal = {Frontiers in immunology}, year = {2021}, doi = {10.3389/fimmu.2021.794519}, pmid = {35173707}, url = {https://doi.org/10.3389/fimmu.2021.794519} } @article{vanmaurik2019-31526625, author = {van Maurik, I. S. and Vos, S. J. and Bos, I. and Bouwman, F. H. and Teunissen, C. E. and Scheltens, P. and Barkhof, F. and Frolich, L. and others}, title = {{Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study}}, journal = {The Lancet. Neurology}, year = {2019}, doi = {10.1016/s1474-4422(19)30283-2}, pmid = {31526625}, url = {https://doi.org/10.1016/s1474-4422(19)30283-2} } @article{reimand2020-32913020, author = {Reimand, J. and Collij, L. and Scheltens, P. and Bouwman, F. and Ossenkoppele, R. and {Alzheimer's Disease Neuroimaging Initiative}}, title = {{Association of amyloid-β CSF/PET discordance and tau load 5 years later}}, journal = {Neurology}, year = {2020}, doi = {10.1212/wnl.0000000000010739}, pmid = {32913020}, url = {https://doi.org/10.1212/wnl.0000000000010739} } @article{babapourmofrad2020-32788242, author = {Babapour Mofrad, R. and Tijms, B. M. and Scheltens, P. and Barkhof, F. and van der Flier, W. M. and Sikkes, S. A. M. and Teunissen, C. E.}, title = {{Sex differences in CSF biomarkers vary by Alzheimer disease stage and APOE ε4 genotype}}, journal = {Neurology}, year = {2020}, doi = {10.1212/wnl.0000000000010629}, pmid = {32788242}, url = {https://doi.org/10.1212/wnl.0000000000010629} } @article{jutten2021-34550903, author = {Jutten, R. J. and Sikkes, S. A. M. and Van der Flier, W. M. and Scheltens, P. and Visser, P. J. and Tijms, B. M. and {Alzheimer's Disease Neuroimaging Initiative}}, title = {{Finding Treatment Effects in Alzheimer Trials in the Face of Disease Progression Heterogeneity}}, journal = {Neurology}, year = {2021}, doi = {10.1212/wnl.0000000000012022}, pmid = {34550903}, url = {https://doi.org/10.1212/wnl.0000000000012022} } @article{vermunt2019-31068481, author = {Vermunt, L. and van Paasen, A. J. L. and Teunissen, C. E. and Scheltens, P. and Visser, P. J. and Tijms, B. M. and {Alzheimer's Disease Neuroimaging Initiative}}, title = {{Alzheimer disease biomarkers may aid in the prognosis of MCI cases initially reverted to normal}}, journal = {Neurology}, year = {2019}, doi = {10.1212/wnl.0000000000007609}, pmid = {31068481}, url = {https://doi.org/10.1212/wnl.0000000000007609} } @article{visser1999-10431775, author = {Visser, P. J. and Scheltens, P. and Verhey, F. R. and Schmand, B. and Launer, L. J. and Jolles, J. and Jonker, C.}, title = {{Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment}}, journal = {Journal of neurology}, year = {1999}, doi = {10.1007/s004150050387}, pmid = {10431775}, url = {https://doi.org/10.1007/s004150050387} } @article{willemse2021-34006321, author = {Willemse, E. A. J. and Scheltens, P. and Teunissen, C. E. and Vijverberg, E. G. B.}, title = {{A neurologist's perspective on serum neurofilament light in the memory clinic: a prospective implementation study}}, journal = {Alzheimer's research \& therapy}, year = {2021}, doi = {10.1186/s13195-021-00841-4}, pmid = {34006321}, url = {https://doi.org/10.1186/s13195-021-00841-4} }